<DOC>
	<DOCNO>NCT01522807</DOCNO>
	<brief_summary>The purpose study evaluate plasma drug concentration three formulation PF-05190457 administration single dose healthy volunteer .</brief_summary>
	<brief_title>A Study Of Three PF-05190457 Formulations In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male female nonchildbearing potential age 21 55 year , BMI 17.5 30.5 kg/m^2 , weight 50 kg . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Single Doses</keyword>
	<keyword>Biocomparison</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>